TransMedics Group, Inc. (BIT:1TMDX)

Market Cap	3.15B
Revenue (ttm)	452.40M
Net Income (ttm)	61.02M
Shares Out	n/a
EPS (ttm)	1.72
PE Ratio	51.57
Forward PE	42.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	96.98
Previous Close	96.98
Day's Range	96.98 - 96.98
52-Week Range	78.74 - 125.75
Beta	n/a
RSI	41.64
Earnings Date	Oct 31, 2025

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung trans...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1998
• Employees: 728
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1TMDX

Financial Performance

Financial numbers in USD